Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LKFT compared with XLO: revenue, margins and what each company keeps, and the suppliers and customers both name
LKFT
Lakefront Biotherapeutics NV
Change
Mkt cap
Revenue
Revenue
XLO
Xilio Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LKFT
Lakefront Biotherapeutics NV
vs
XLO
Xilio Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LKFT
2
GILD
Gilead Sciences
customer
—
Alfasigma
unlisted
customer
Shared
0
No disclosed counterparties: XLO.
Only XLO
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
LKFT
Lakefront Biotherapeutics NV
Change
32.15
▲
+0.40%
Mkt cap
$2.1B
Revenue
—
Revenue
—
XLO
Xilio Therapeutics, Inc.
Change
8.51
▲
+6.54%
Regular session
Nov 3 '26
Mkt cap
$155.0M
Revenue
$19M
Q2 FY26
Revenue
$44M
FY25
vs
Compare
Regular session
Nov 3 '26
LKFT
Lakefront Biotherapeutics NV
vs
XLO
Xilio Therapeutics, Inc.
32.15
▲
+0.40%
Price
8.51
▲
+6.54%
$2.1B
Mkt cap
$155.0M
—
Revenue
$19M
Q2 FY26
—
Revenue
$44M
FY25
Change
Change
LKFT
32.15
▲
+0.40%
vs
XLO
8.51
▲
+6.54%
Regular session
Nov 3 '26